ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction.
Tomomi Kawakita, Toshiki Sekiya, Yayoi Kameda, Naoki Nomura, Marumi Ohno, Chimuka Handabile, Akari Yamaya, Hideo Fukuhara, Yuki Anraku, Shunsuke Kita, Shinsuke Toba, Hirotake Tsukamoto, Tomohiro Sawa, Hiroyuki Oshiumi, Yasushi Itoh, Katsumi Maenaka, Akihiko Sato, Hirofumi Sawa, Yasuhiko Suzuki, Lorena E Brown, David C Jackson, Hiroshi Kida, Misako Matsumoto, Tsukasa Seya, Masashi Shingai
Journal of virology, 2025年04月, 査読有り